Prevention of diazepam-induced thrombophlebitis with cremophor as a solvent. 1979

M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen

In 104 patients undergoing anaesthesia of short duration, two different solvents, propylene glycol and cremophor, were compared in a double-blind trial. Diazepam 10 mg in a coded solution was injected into a superficial vein of the hand using a small-gauge needle. The vein was examined after 14 days. The frequency of thrombophlebitis with propylene glycol was 62.2% and with cremophor 3.4% (P less than 0.001). The frequency of pain on injection was also in favour of the new solvent (P less than 0.001). The possibility of anaphylactic reactions accredited to cremophor, however, restricts the use of the new injection.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011409 Propylene Glycols Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations. Propanediols,Glycols, Propylene
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
January 1980, British journal of anaesthesia,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
June 1981, Journal of the American Dental Association (1939),
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
July 1974, British medical journal,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
September 1980, Journal of the American Dental Association (1939),
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
January 1973, JAMA,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
January 1988, Indian journal of physiology and pharmacology,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
September 1973, JAMA,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
April 1982, Journal of the Royal Society of Medicine,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
October 1981, British dental journal,
M A Mattila, and M Ruoppi, and M Korhonen, and H M Larni, and L Valtonen, and H Heikkinen
July 1981, British dental journal,
Copied contents to your clipboard!